Hypericum perforatum L induced wound healing process in Freund's adjuvant arthritic rats.
Hypericum perforatum L (Hp) beneficial properties in wound healing
have been known since the era of Hippocrates. The aim of the study was
to investigate the restoration quality of incised skin under locally
oily Hp Rotoel[R] treatment in Freund's adjuvant arthritis Wistar
rats. Histological skin specimens of rats were evaluated under light
microscopy (x20 HE). Controls and adjuvant arthritis rats under Hp had a
more rapid formation of granoulomatous tissue compared with non treated
controls. Hp treatment ameliorated inflammatory laboratory findings. In
conclusion Hp treatment seems to contribute to more rapid wound repair
and its application may be considered helpful in surgical practice.
Key words: Hypericum perforatum L, wound, Freund's adjuvant
(Care and treatment)
Wound healing (Methods)
Adjuvants, Pharmaceutic (Research)
St. John's wort (Health aspects)
|Publication:||Name: Australian Journal of Medical Herbalism Publisher: National Herbalists Association of Australia Audience: Academic Format: Magazine/Journal Subject: Health Copyright: COPYRIGHT 2011 National Herbalists Association of Australia ISSN: 1033-8330|
|Issue:||Date: Spring, 2011 Source Volume: 23 Source Issue: 1|
|Topic:||Event Code: 310 Science & research|
|Geographic:||Geographic Scope: Australia Geographic Code: 8AUST Australia|
A wound is defined as the tissue disruption of the cellular and anatomic continuity. The process of wound healing consists of integrated cellular and biochemical events leading to re-establishment of structural and functional integrity with regain of strength of injured tissue. The management of wound healing has been a primary care of people since the beginning of civilization. Nature offers an immense source of medicinal herbs in the service of humanity. The art of herbal healing is deep rooted in folk medicine.
Hypericum genus (St John's wort), originating in Europe, West Asia and North Africa, is one of the oldest and the best experimentally and clinically examined herbal remedies in various cultures and medical systems.
Different species of the genus Hypericum (Hypericaceae) have been used in traditional medicine to treat various diseases. Hypericum perforatum L has been shown to possess significant wound healing properties since Hippocrates era (Hippocrate 1839). Hypericum perforatum particularly has been administered for skin wounds treatment, eczema, gastrointestinal and psychological disorders (Bombardelli 1995, Barnes 2001, Sapounakis 2009). Hypericum perforatum and other species of the genus Hypericum possess anxiolytic, antiviral, antimicrobial, analgesic, anti-inflammatory and antioxidant properties, while recently interest has been directed towards the antidepressant activity of this plant extract (Axarlis 1998, Flausino 2002, Mattace Raso 2002, Brenner 2000, Rabanal 2005).
In Canary Islands folk medicine, flowers, leaves and fruit infusions of various Hypericum taxa, especially of the endemic Hypericum reflexum L, have been used as external wound ulcer treatment and also as sedative, diuretic, vermifuge, antihysteric and antidepressant agents. The methanolic extract as well as the chloroform and butanol fractions of Hypericum reflexum were reported to possess antibacterial properties against gram positive bacteria (Darias 1986, Rabanal 2002, Herrera 1996). Although Kumar and Singh (2001) have demonstrated the analgesic and anti-inflammatory activity of Hypericum extracts, these properties have not yet been fully elucidated (Kumar 2001).
The aim of this study therefore was to investigate the wound healing effect of Hypericum perforatum flowers sojaoil extract (Rotoel[R]) in a model of experimental trauma in Freund's adjuvant arthritic Wistar rats.
Material and methods Animals
Four groups (I, II, III, IV) of 8 male Wistar rats each, aged 5-6 weeks and weighting 250 [+ or -] 15 g were used. Group I and II served as control. Animals were housed in a controlled environment with 12 h light/12 h darkness and had access to standard rodent chow and water ad libitum. The animals were treated in accordance with standard principles (Washington 1985).
Freund's adjuvant induced arthritis
The animals of group III, IV were intradermally injected with 0.1 mL complete Freund's adjuvant (CFA) (Sigma-Aldrich) into the right hindpaw as in previous studies (Anagnostou 2009, Tigka 2005). Each mL contained 1 mg of Mycobacterium tuberculosis (H37Ra, ATCC 25177 Sigma-Aldrich St. Louis USA), heat killed and dried, 0.85 mL paraffin oil and 0.15 mL mannide monooleate. Two days after the CFA injection the experimental arthritis manifestations were observed. The evaluation of the CFA induction was assessed via the clinical signs, e.g. changes in weight (organ weight/body weight) of adrenals, spleen, thymus and the increases in paw diameter.
Experimental wound induction
All animals were anesthetised with ether pro narcosi, depilated in dorsal area and skin trauma was performed with a punch out 6 mm instrument for dermal biopsy until the muscular aponevrose in order to have a similar trauma in length and deepness in all animals.
The animals of groups II and IV were treated daily with a local application of 10 [micro]L Hypericum perforatum oily preparation (Rotoel[R] Jukunda) containing 10% Hypericum flos using a micropipette.
Central sections of skin specimens obtained 5 days after the local application of Rotoel[R] in the incised dorsal area of animals, were embedded in paraffin in sections of 5[micro]. Three sections of every sample were stained with Haematoxilin-Eosin and evaluated under the light microscopy (x20).
Blood was collected and laboratory parameters (rheumatoid factor, CRP, total proteins, albumin, globulin, interleukin-2, interleukin-6) were measured in order to assess the successful induction of experimental adjuvant arthritis. Commercial enzyme linked immunosorbent assay (ELISA) kits for the quantitation of IL- 2 and IL-6 were employed. All ELISA kits were used according to the instruction manuals.
The data from the experimental and control rats were statistically analyzed by t- test .
Clinical manifestation of Freund's adjuvant arthritis
Adjuvant arthritis evaluation resulting from clinical manifestation showed an augmentation in right paw diameter in groups III and IV compared with the controls. Similarly body weight was decreased in the CFA arthritic group (p<0.05) and was non statistically significantly re-established with Hypericum perforatum treatment.
The relative organ weights of spleen and adrenals were increased in CFA arthritic animals (p<0.05) while thymus relative weight declined (p<0.05) (Table 1).
The inhibition of paw edema was calculated with reference to the control group. Hypericum perforatum treatment demonstrated a non statistical significant curative effect on the systemic changes which occur in adjuvant arthritic rats (mean value [+ or -] SD).
Laboratory findings of experimental v. control groups
The laboratory findings indicate an enhancement of rheumatoid factor (Rf), C-reactive protein (CRP), globulin, interleukin-2, interleukin-6, while albumin and total proteins were decreased in the adjuvant arthritis groups compared with the controls. The albumin/globulin ratio was reversed in CFA arthritic animals. Freund's adjuvant arthritis changed all the measured inflammatory parameters statistically significantly (p<0.05). In addition a tendency to the arthritis profile amelioration was observed under the influence of Hypericum perforatum (Table 2).
The specimens of skin incision area demonstrated that the control animals treated with Hypericum perforatum had a much more rapid formation of granoulomatous tissue in comparison to the non treated groups.
The CFA arthritis rats demonstrated a delay in skin healing process, but Hypericum perforatum treatment induced a more rapid formation of granulomatous tissue, advanced wound healing and wound shrinkage compared with non treated animals.
The healing properties of the Hp oil extract local administration are obvious in the controls and arthritic animals in accordance with the traditional local use of Hp as a wound healing agent. The local application of H. perforatum is already considered a safe medium for the facilitation of cesarean wound healing and the minimisation of scar formation, pain and pruritus (Samadi 2010).
The model of adjuvant arthritis was successfully induced as implied by the augmentation of paw diameter, one of the major factors assessing the degree of inflammation and the efficacy of various potential anti-inflammatory substances.
All parameters of inflammation were attenuated by H. perforatum extract. Parallel with Hp beneficial effect on the wound healing in control animals, Freund's adjuvant arthritis injuries tend to be repaired after Hp treatment as is verified by the biochemical findings. This is in accordance with similar data demonstrating analgesic and anti-inflammatory effects of various Hypericum species in mice models either with tetradecanoylphorbol acetate (TPA) induced ear inflammation (Rabanal 2005, Sanchez-Mateo 2006), zymosan induced organ dysfunction syndrome or of carrageenan induced pleuritis (Sanchez-Mateo 2006, Di Paola 2007).
The anti-inflammatory effect of Hp is attributed by Bezakova et al (1999) to its isolated constitutes anthrone, anthroquinone, emodin hypericin and pseudohypericin while its analgesic effect may be attributed to the presence of flavonoids, tannins and saponins (Sanchez-Mateo 2006, Bezakova 1999). Moreover the Hypericum anti-inflammatory effect is ascribed to the lipoxygenase activity inhibition and to the decrease of prostaglandine E (Bezakova 1999, Hammer 2007).
It must be mentioned that oil extracts of Hypericum perforatum (Oleum Hyperici) healing effect is independent of lesion origin since it is reported to exert gastroprotective, healing and palliative activity on gastric mucosa ulcers induced by NSAIDs such as indomethacin (Zduni 2009).
Furthermore in an evaluation study of Hypericum patulum leaf extract skin wound healing activity in rats compared with nitrofurazone ointment it was documented that leaf extract ointments lead to more effective tissue regeneration than the antibacterial agent (Mukherjee 2000).
It must be noted that although the present study as well as other reports confirm the healing effect of Hp after local application, they did not show considerable systemic Hp activity since it did not ameliorate the whole Freund's adjuvant arthritis multiple organ dysfunction syndrome. Probably the way of administration is responsible for the low systemic concentration of the active substances due to the local application.
It may be concluded that Hypericum perforatum treatment contributes to a more rapid tissue repair of the wound area probably via its constituents even in local application, showing a reduced tendency on the inflammation parameters and this may be useful in surgical practice.
The above results confirm the use of Hypericum perforatum as a potential wound healing agent, a property recognised in folklore medicine.
Anagnostou M, Chatzigianni E, Doucoudakis S, Potamianou A, Tesseromatis C. 2009. Biocompatibility of resin composites subcutaneously implanted in rats with experimentally induced arthritis. Dent Mater 25:7;863-7
Axarlis A, Mentis C, Dementzos S, Mitaku AL, Skaltsounis M, Marselos M, Malamas M. 1998. Antiviral in vitro activity of Hypericum perforatum L. extracts on the human cytomegalovirus (HCMV). Phytother Res 12;507-11.
Barnes J, Anderson LA, Phillipson JD. 2001. St John's wort (Hypericum perforatum L): a review of its chemistry, pharmacology and clinical properties. JPharm & Pharmacol 53;583-600.
Bezakova L, Psenak M, Kartnig T. 1999. Effect of dianthrones and their precursors from Hypericum perforatum L on lipoxygenase activity. Pharmazie 54:9;711.
Bombardelli E, Morazzoni P. 1995. Hypericum perforatum L. Fitoterapia 66;43-68.
Brenner R, Azbel V, Madhusoodanan S, Pawlowska M, 2000. Comparison of an extract of Hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study, Clinical Ther 22;411-19.
Colpaert FC, Meert T, DeWitte P, Schmitt P. 1982. Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat. Life Sci 31;67-75.
Darias V, Bravo L, Barquin E, Martin-Herrera D, Fraile C. 1986. Contribution to the ethnopharmacological study of the Canary Islands. J Ethnopharmacol 15;169-93.
Di Paola R, Mazzon E, Muia C et al. 2007. Protective effect of Hypericum perforatum L in zymosan-induced multiple organ dysfunction syndrome: Relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. Nitric Oxide 16:1;118-30.
Firestein GS, Manning AM. 1999. Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum 42;609-21.
Firestein GS. 2003. Evolving concepts of rheumatoid arthritis. Nature 423;356-61.
Firth J, Siddle H. 2009. Management of foot ulceration in patients with rheumatoid arthritis. Nurs Stand 23:24;64-6.
Flausino OA, Zangrossi Jr H, Salgado Jr JV, Viana MB. 2002. Effects of acute and chronic treatment with Hypericum perforatum L (LI 160) on different anxiety-related responses in rats. Pharmacol, Biochem & Behav 71;259-65.
Hammer KDP, Hillwig ML, Solco AKS, Dixon KD, Murphy PA, Wurtele ES, Birt DF. 2007. Inhibition of PGE2 production P.M. by anti-inflammatory Hypericum perforatum L extracts and constituents in RAW 264.7 mouse macrophage cells. J Agric Food Chem 55;7323-31.
Herrera RM, Perez M, Martin-Herrera DA, Lopez-Garcia R, Rabanal RM. 1996. Antimicrobial activity of extracts from plants endemic to the Canary Islands. Phytother Research 10;364-66.
Hippocrate. 1839-1861. Oeuvres completes /Em. Littre Vol 8. DesMaladies des femmes 78:80;194. Paris: Ed Trad.
Hirschelmann R, Schade R. 1986. Regulation of acute phase reaction in rat adjuvant arthritis. Agents Actions 19;335-6.
Kumar V, Singh PN, Bhattacharya SK. 2001. Anti-inflammatory and analgesic activity of Indian Hypericum perforatum L. Indian J Exp Biol 39:4;339-43.
Mattace Raso G, Pacilio M, Di Carlo G, Esposito E, Pinto L, Meli R. 2002. In-vivo and in-vitro anti-inflammatory effect of Echinacea purpurea and Hypericum perforatum L. J Pharm & Pharmacol 54;1379-83.
Menegazzi M, Di Paola R, Mazzon E, Muia C, Genovese T, Crisafulli C, Suzuki H, Cuzzocrea S. 2006. Hypericum perforatum L attenuates the development of carrageenan induced lung injury in mice. Free Radic Biol Medicine 40:5;740-53.
Mukherjee P, Verpoorte R, Suresh B. 2000. Evaluation of in-vivo wound healing activity of Hypericum patulum (Family: Hypericaceae) leaf extract on different wound model in rats. J Ethnopharmacol 70:3;315-21.
Rabanal RM, Bonkanka CX, Hernandez-Perez M, Sanchez-Mateo CC. 2005. Analgesic and topical anti-inflammatory activity of Hypericum canariense L. and Hypericum glandulosum Ait. J Ethnopharmacol
Rabanal RM, Arias A, Prado B, Hernandez-Perez MSanchez-Mateo CC. 2002. Antimicrobial studies on three species of Hypericum from the Canary Islands, J Ethnopharmacol 81;287-92.
Ruth JH, Rottman JB, Katschke KJ. 2001. Selective lymphocyte chemokine receptor expression in the rheumatoid joint. Arthritis Rheum 44;2750-60.
Sanchez-Mateo CC, Bonkanka CX, Hernandez-Perez M, Rabanal RM. 2006. Evaluation of the analgesic and topical anti-inflammatory effects of Hypericum reflexum L. J Ethnopharmacol 107:1;1-6.
Sapounakis C,Tesseromatis C. 2009. Hypericum perforatum L: a traditional remedy with new indications. Rev Clin Pharmacol & Pharmacokinet Int Ed 23;73-6.
Samadi S, Khadivzadeh T, Emami A et al. 2010. The effect of Hypericum perforatum L on the wound healing and scar of cesarean. JACM. 16:1;113-17.
Tigka E, Daskala I, Rallis G, Anagnostopoulou S, Tesseromatis C. 2005. Adjuvant arthritis-induced changes on ampicillin binding in serum and tissues under the influence of nonsteroidal anti-inflammatory drugs in rats. Eur J Drug Metab Pharmacokinet 30:4;235-41.
National Research Council, Committee on care and use of laboratory animals. 1985. Guides for the care and use of laboratory animals. Washington DC: Institute of laboratory animals and resources.
Zduni G, Goevac D, Milenkovi M, Vuievi D, Avikin K, Menkovi N, Petrovi S. 2009. Evaluation of Hypericum perforatum L oil extracts for an antiinflammatory and gastroprotective activity in rats. Phytother Research 23:11;1559-64.
Sapounakis Constatin is a Medical Doctor and General Practioner, Department of Pharmacology, Medical School, University of Athens, Greece
Kotsiou Antonia PHD is a pharmacist in the Department of Pharmacology, Medical School, University of Athens, Greece
Potamianou Aggella MD PHD is a Biopathologist in the Department of Microbiology, Asklipio General Hospital of Voula, Athens, Greece
Tsamouri Madalaine MD PHD is a pathologist in the Department of Pathology, Red Cross Hospital, Athens Greece
Vovou Joanna PHD is a biologist in the Department of Pharmacology, Medical School, University of Athens, Greece
Tesseromatis Christine MD PHD is an Associate Professor of Pharmacology Department of Pharmacology, Medical School, University of Athens, Greece
Sapounakis C (1), Kotsiou A (1), Potamianou A (2), Tsamouri M (3), Vovou J (1), Tesseromatis C (1) *
(1) Department of Pharmacology, Medical School, University of Athens, 75 Mikras Asias St, Goudi Athens 11527 Greece
(2) Department of Microbiology, Asklipio General Hospital of Voula, Athens Greece
(3) Department of Pathology, Red Cross Hospital, Athens Greece
* Corresponding author email: email@example.com
Table 1: Clinical manifestations of CFA arthritis with and without Hypericum perforatum treatment in comparison with the controls Groups Controls I Body weight (g) 250 [+ or -] 15 Thymus weight (g/g x 10-3) 1. 02 [+ or -] 0.04 Spleen weight (g/g x 10-3) 1.09 [+ or -] 0.13 Adrenals weight (g/g x 10-3) 0.05 [+ or -] 0.04 Paw diameter (mm) 5 [+ or -] 0.5 Groups Controls + Hp II Body weight (g) 248 [+ or -] 10 Thymus weight (g/g x 10-3) 1. 12 [+ or -] 0.07 Spleen weight (g/g x 10-3) 1.12 [+ or -] 0.09 Adrenals weight (g/g x 10-3) 0.05 [+ or -] 0.27 Paw diameter (mm) 5 [+ or -] 0.5 Groups CFA III Body weight (g) 205 [+ or -] 12 * Thymus weight (g/g x 10-3) 0.72 [+ or -] 0.11 * Spleen weight (g/g x 10-3) 1.43 [+ or -] 0.12 * Adrenals weight (g/g x 10-3) 0.08 [+ or -] 0.01 * Paw diameter (mm) 8.5 [+ or -] 0.2 * Groups CFA + Hp IV Body weight (g) 215 [+ or -] 8 (#) Thymus weight (g/g x 10-3) 0,98 [+ or -] 0.03 (#) Spleen weight (g/g x 10-3) 1.35 [+ or -] 0.1 (#) Adrenals weight (g/g x 10-3) 0.068 [+ or -] 0.03 (#) Paw diameter (mm) 7.8 [+ or -] 0.3 (#) Groups * I/III p <0.05 (#) II/IV p<0.5 (#) III/IV p<0.5 Table 2: Changes in laboratory findings in CFA arthritic animals compared with controls with and without Hypericum perforatum treatment Groups M [+ or -] SD Control Controls + Hp II Rf IU/ml >9.5 >9.5 CRPmg/L >3.5 >3.5 Total proteins 1.09 [+ or -] 0.13 1.12 [+ or -] 0.09 (g/dl) 6.9 [+ or -] 0.1 7 [+ or -] 0.5 Albumin 5 [+ or -] 0.5 5 [+ or -] 0.5 (g/dl) 4.1 [+ or -] 0.01 4.25 [+ or -] 0.01 Globulin (g/dl) 2.41 [+ or -] 0.21 2.56 [+ or -] 0.04 Groups M [+ or -] SD CFA arthritis III CFA arthritis + Hp IV Rf IU/ml 15.65 [+ or -] 0.01 * 10.5 [+ or -] 0.2 * CRPmg/L 5.3 [+ or -] 0.3 * 4.1 [+ or -] 0.02 * Total proteins 1.43 [+ or -] 0.12 * 1.35 [+ or -] 0.1 (#) (g/dl) 6.15 [+ or -] 0.02 * 6.35 [+ or -] 0.2 * Albumin 8.5 [+ or -] 0.2 * 7.8 [+ or -] 0.3 (#) (g/dl) 3 [+ or -] 0.02 3.7 [+ or -] 0.02 * Globulin (g/dl) 4.4 [+ or -] 0.2 4.01 [+ or -] 0.3 Groups * I/III p <0.05 (#) II/IV p<0.5 (#) III/IV p<0.5
|Gale Copyright:||Copyright 2011 Gale, Cengage Learning. All rights reserved.|